Close

Brean Murray Carret & Co. Maintains a 'Sell' on Vivus; Orexigen (OREX) News Not Immediately Relevant to VVUS Sep 21, 2011 08:56AM
Brean Murray Carret & Co. Reiterates Sell Rating and $2 Price Target on Vivus (VVUS), No Real Signs Of Success May 3, 2011 10:37AM
Game Over For VIVUS (VVUS) According to Brean Murray Mar 4, 2011 11:52AM
Notable Analyst Rating Changes 08/03: NWL, MTW, SHPGY, PHH Upgraded; AMAT, SYKE, AZO, VVUS Downgraded Aug 3, 2010 11:11AM
Brean Murray Cuts VIVUS (VVUS) to Sell Amid Q2 Miss; $2 Price Target Implies 64% Slide in Stock Price Aug 3, 2010 09:12AM


Jul 16, 2010 01:13PM Unusual 11 Mid-Day Movers 07/16: LSBX, ARNA, AVII, CYPB, SCHW, TSLA Higher; VVUS, JST, ROIAK, OREX, PLCM Lower
Jul 16, 2010 10:46AM Notable Analyst Rating Changes 07/16: GS, JPM, ARNA, ADM Upgraded; VVUS, BP, RBA, OREX Downgraded
Jul 16, 2010 10:14AM Morning Movers 7/16: LSBX, ARNA, AVII Higher; VVUS, JST, VRNM, BIOF, VIDE, PLCM Lower
Jul 16, 2010 08:19AM Brean Murray Downgrades VIVUS (VVUS) to Hold
Jul 13, 2010 03:27PM Brean Murray Sees VIVUS's (VVUS) Qnexa Gaining FDA Approval, Raises Target to $18
Jun 16, 2010 03:04PM Vivus (VVUS) option prices elevated into data
Apr 27, 2010 11:01AM Notable Analyst Rating Changes 04/27: PPDI, MRVL, TASR, CAVM Upgraded; AIG, HBAN, NWSA, ACN Downgraded
Apr 27, 2010 09:47AM Brean Murray Initiates Coverage on VIVUS, Inc. (VVUS) with a Buy; Meaningful Near-Term Catalysts